Longer Gleevec Use Ups Survival in Gut Tumor (CME/CE)

(MedPage Today) — Adjuvant imatinib (Gleevec) treatment given for a longer period of time was superior to therapy for only a year following surgery for gastrointestinal stromal tumors, an open-label study found.

Post a Comment

Comments are closed.